These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20063992)

  • 1. Development of two avidity-based assays to detect recent HIV type 1 seroconversion using a multisubtype gp41 recombinant protein.
    Wei X; Liu X; Dobbs T; Kuehl D; Nkengasong JN; Hu DJ; Parekh BS
    AIDS Res Hum Retroviruses; 2010 Jan; 26(1):61-71. PubMed ID: 20063992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence.
    Parekh BS; Kennedy MS; Dobbs T; Pau CP; Byers R; Green T; Hu DJ; Vanichseni S; Young NL; Choopanya K; Mastro TD; McDougal JS
    AIDS Res Hum Retroviruses; 2002 Mar; 18(4):295-307. PubMed ID: 11860677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.
    Duong YT; Qiu M; De AK; Jackson K; Dobbs T; Kim AA; Nkengasong JN; Parekh BS
    PLoS One; 2012; 7(3):e33328. PubMed ID: 22479384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a novel rapid HIV test for simultaneous detection of recent or long-term HIV type 1 infection using a single testing device.
    Granade TC; Nguyen S; Kuehl DS; Parekh BS
    AIDS Res Hum Retroviruses; 2013 Jan; 29(1):61-7. PubMed ID: 23281586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of antibody assays for identifying and distinguishing recent from long-term HIV type 1 infection.
    Parekh BS; Pau CP; Kennedy MS; Dobbs TL; McDougal JS
    AIDS Res Hum Retroviruses; 2001 Jan; 17(2):137-46. PubMed ID: 11177393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High avidity anti-integrase antibodies discriminate recent and non-recent HIV infection: Implications for HIV incidence assay.
    Rikhtegaran Tehrani Z; Azadmanesh K; Mostafavi E; Gharibzadeh S; Soori S; Azizi M; Khabiri A
    J Virol Methods; 2018 Mar; 253():5-10. PubMed ID: 29248529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes.
    Duong YT; Kassanjee R; Welte A; Morgan M; De A; Dobbs T; Rottinghaus E; Nkengasong J; Curlin ME; Kittinunvorakoon C; Raengsakulrach B; Martin M; Choopanya K; Vanichseni S; Jiang Y; Qiu M; Yu H; Hao Y; Shah N; Le LV; Kim AA; Nguyen TA; Ampofo W; Parekh BS
    PLoS One; 2015; 10(2):e0114947. PubMed ID: 25710171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a New Limiting-Antigen Avidity Dot Immuno-Gold Filtration Assay for HIV-1 Incidence.
    Gao Z; Yan H; Feng X; Wu L; Qiu M; Xing W; Zhang G; Zhang Z; Jiang Y
    PLoS One; 2016; 11(8):e0161183. PubMed ID: 27513563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant envelope protein of HIV-1 subtype E as antigen in HIV-1 antibody detection enzyme immunoassay.
    Sutthent R; Kanoksinsombat C; Horthongkham N; Louisirirotchanakul S; Auewarakul P; Kantakamalakul W
    Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):288-96. PubMed ID: 12236427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a sensitive/less sensitive testing algorithm using the bioMérieux Vironostika-LS assay for detecting recent HIV-1 subtype B' or E infection in Thailand.
    Young CL; Hu DJ; Byers R; Vanichseni S; Young NL; Nelson R; Mock PA; Choopanya K; Janssen R; Mastro TD; Mei JV
    AIDS Res Hum Retroviruses; 2003 Jun; 19(6):481-6. PubMed ID: 12882657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of HIV-1 genotype specific antigens for the detection of recent and long-term HIV-1 infection in China.
    Cai Q; Wang H; Huang L; Yan H; Zhu W; Tang S
    Virus Res; 2019 Apr; 264():16-21. PubMed ID: 30794896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Evaluation of a Modified Fourth-Generation Human Immunodeficiency Virus Enzyme Immunoassay for Cross-Sectional Incidence Estimation in Clade B Populations.
    Kirkpatrick AR; Patel EU; Celum CL; Moore RD; Blankson JN; Mehta SH; Kirk GD; Margolick JB; Quinn TC; Eshleman SH; Laeyendecker O
    AIDS Res Hum Retroviruses; 2016 Aug; 32(8):756-62. PubMed ID: 26988426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved testing of recent HIV-1 infections with the BioRad avidity assay compared to the limiting antigen avidity assay and BED Capture enzyme immunoassay: evaluation using reference sample panels from the German Seroconverter Cohort.
    Hauser A; Santos-Hoevener C; Meixenberger K; Zimmermann R; Somogyi S; Fiedler S; Hofmann A; Bartmeyer B; Jansen K; Hamouda O; Bannert N; Kuecherer C
    PLoS One; 2014; 9(6):e98038. PubMed ID: 24892795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of recent HIV infections in African individuals infected by HIV-1 non-B subtypes using HIV antibody avidity.
    Suligoi B; Buttò S; Galli C; Bernasconi D; Salata RA; Tavoschi L; Chiappi M; Mugyenyi P; Pimpinelli F; Kityo C; Regine V; Rezza G
    J Clin Virol; 2008 Apr; 41(4):288-92. PubMed ID: 18248848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda.
    Brennan CA; Lund JK; Golden A; Yamaguchi J; Vallari AS; Phillips JF; Kataaha PK; Jackson JB; Devare SG
    AIDS; 1997 Dec; 11(15):1823-32. PubMed ID: 9412700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of a bead-based, multiplex assay for estimation of recent HIV type 1 infection.
    Curtis KA; Kennedy MS; Charurat M; Nasidi A; Delaney K; Spira TJ; Owen SM
    AIDS Res Hum Retroviruses; 2012 Feb; 28(2):188-97. PubMed ID: 21585287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of genetic variability within the immunodominant epitopes of envelope gp41 from human immunodeficiency virus type 1 (HIV-1) group M and its impact on HIV-1 antibody detection.
    Dorn J; Masciotra S; Yang C; Downing R; Biryahwaho B; Mastro TD; Nkengasong J; Pieniazek D; Rayfield MA; Hu DJ; Lal RB
    J Clin Microbiol; 2000 Feb; 38(2):773-80. PubMed ID: 10655384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antibodies against the 15 amino acid sequence 599-613 of HIV-1 glycoprotein 41 in subjects at risk of HIV infection].
    Nardi G; Zanchetta N; Maiolani M; Berlusconi A; Salvaggio L
    Boll Ist Sieroter Milan; 1989; 68(3):277-83. PubMed ID: 2491437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes.
    Chawla A; Murphy G; Donnelly C; Booth CL; Johnson M; Parry JV; Phillips A; Geretti AM
    J Clin Microbiol; 2007 Feb; 45(2):415-20. PubMed ID: 17151211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of human immunodeficiency virus type 1 (HIV-1) gp41 variability on antibody detection.
    Nie J; Song A; Xu S; Li X; Wang Y
    Arch Virol; 2010 Nov; 155(11):1813-22. PubMed ID: 20689972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.